THE DEAL, AT A GLANCE
From the announcementEG427
01Who is involvedBacked by this authorFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedEG427 raised $37.7M Series C, announced 2026-07-07From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersEG427's $37.7M Series C is a below-median Healthcare & Life Sciences financing in an active funding market, signaling continued capital availability for HSV gene therapy…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
EG427 · Financing Record
Explore source-linked visual explanations for EG427. Unsupported claims are withheld while source review continues.
Record 7702 · Recorded date: 2026-07-07
Explore company records →